Mereo BioPharma Group (MREO) Earnings Date, Estimates & Call Transcripts $0.29 +0.00 (+0.10%) As of 11:29 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings Mereo BioPharma Group Earnings Summary Mereo BioPharma Group released Q2 2026 earnings on August 12, 2026, reporting an EPS of -$0.01, which hit the consensus estimate of -$0.01. With a trailing EPS of -$0.04, Mereo BioPharma Group's earnings are expected to grow next year, from ($0.04) to ($0.03) per share. Upcoming Q3 Earnings DateNov. 9Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.01 Actual EPS (Aug. 12) -$0.01 Q2 2026 Earnings ResourcesQ2 2026 Earnings Report Press Release (6-K) Quarterly Report (10-Q)SEC FilingMREO Upcoming EarningsMereo BioPharma Group's Q3 2026 earnings is estimated for Monday, November 9, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, November 10, 2026 at 2:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Mereo BioPharma Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mereo BioPharma Group and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataMREO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Mereo BioPharma Group Upcoming Earnings ConsensusReport DateNovember 9, 2026Consensus EPS Estimate-$0.01Consensus Revenue Estimate$4.61MMereo BioPharma Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20261$0.05$0.05$0.05Q2 20261$0.04$0.04$0.04Q3 20261-$0.01-$0.01-$0.01Q4 20261$0.04$0.04$0.04FY 20264$0.12$0.12$0.12 Mereo BioPharma Group Earnings History by Quarter 10/28/2024 - 10/28/2026 Report Date Report Date From Report Date To 3M6MYTD1Y2Y3Y5Y10Y More filters Fewer filters Done 0 Results Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/9/2026(Estimated)--$0.01---$4.61M--8/12/2026Q2 2026-$0.01-$0.01--$0.05$3.50M-5/12/2026Q1 2026$0.02-$0.01 -$0.03-$0.05$11.67M-3/20/2026Q4 2025-$0.01-$0.01--$0.05$5.30M-11/10/2025Q3 2025-$0.0035-$0.01 -$0.0065-$0.05$3.70M-8/12/2025Q2 2025-$0.01-$0.02 -$0.01-$0.02$7.80M$0.50M5/13/2025Q1 2025-$0.01-$0.02 -$0.01-$0.02$72.50M-3/26/2025Q4 2024$0.02-$0.01 -$0.03-$0.01$72.50M- Mereo BioPharma Group Earnings - Frequently Asked Questions When is Mereo BioPharma Group's earnings date? Mereo BioPharma Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 9th, 2026 based off last year's report dates. Learn more on MREO's earnings history. Did Mereo BioPharma Group beat their earnings estimates last quarter? In the previous quarter, Mereo BioPharma Group (NASDAQ:MREO) reported ($0.01) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.01). Learn more on analysts' earnings estimate vs. MREO's actual earnings. How can I view Mereo BioPharma Group's earnings report? Mereo BioPharma Group's earnings report can be found in their filing with the SEC. View SEC filing What is Mereo BioPharma Group's EPS forecast for next year? Mereo BioPharma Group's earnings are expected to grow from ($0.04) per share to ($0.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies Cartesian Therapeutics Earnings Results Sionna Therapeutics Earnings Results ADC Therapeutics Earnings Results Sutro Biopharma Earnings Results Invivyd Earnings Results Eledon Pharmaceuticals Earnings Results Whitehawk Therapeutics Earnings Results Precision BioSciences Earnings Results Akebia Therapeutics Earnings Results Oramed Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir's Q3 Bar Is Higher Than It Looks: 3 Numbers to WatchSherwin-Williams Remains Evergreen in a Frozen Housing MarketTaiwan Semiconductor Flexes Pricing Power on AI's FrontlineIs United Parcel Service Finally Turning the Corner?Hidden in Plain Sight: 2 Earnings Winners Investors May Have MissedApple's Foldable iPhone Sold Out in Minutes, But Wall Street Has QuestionsCoca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength Earnings data for NASDAQ:MREO is sourced from Fiscal.ai, with the most recent quarter reported on 8/12/2026. New results are added as companies report their earnings. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredAnd they say the headline number understates what’s really happening.Goldman Sachs just admitted it underestimated central bank gold purchases by more than 500 percent, with buyin...Cedar Gold Group | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
